Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2018 1
2020 1
2021 2
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
First German-speaking harm reduction conference in Vienna.
Steimle L, Fleißner S, Haltmayer H, Beck T, Springer A, Stöver H. Steimle L, et al. Among authors: haltmayer h. Harm Reduct J. 2024 Jan 16;21(1):12. doi: 10.1186/s12954-024-00932-z. Harm Reduct J. 2024. PMID: 38229089 Free PMC article.
Towards an International Consensus on the Prevention, Treatment, and Management of High-Risk Substance Use and Overdose among Youth.
Krausz M, Westenberg JN, Tsang V, Suen J, Ignaszewski MJ, Mathew N, Azar P, Cabanis M, Elsner J, Vogel M, Spijkerman R, Orsolini L, Vo D, Moore E, Moe J, Strasser J, Köck P, Marian C, Dürsteler KM, Backmund M, Röhrig J, Post M, Haltmayer H, Wladika W, Trabi T, Muller C, Rechberger G, Teesson M, Farrell M, Christie G, Merry S, Mamdouh M, Alinsky R, Levy S, Fishman M, Rosenthal R, Jang K, Choi F. Krausz M, et al. Among authors: haltmayer h. Medicina (Kaunas). 2022 Apr 13;58(4):539. doi: 10.3390/medicina58040539. Medicina (Kaunas). 2022. PMID: 35454376 Free PMC article.
Directly observed therapy for HCV with glecaprevir/pibrentasvir alongside opioid substitution in people who inject drugs-First real world data from Austria.
Schmidbauer C, Schubert R, Schütz A, Schwanke C, Luhn J, Gutic E, Pirker R, Lang T, Reiberger T, Haltmayer H, Gschwantler M. Schmidbauer C, et al. Among authors: haltmayer h. PLoS One. 2020 Mar 10;15(3):e0229239. doi: 10.1371/journal.pone.0229239. eCollection 2020. PLoS One. 2020. PMID: 32155165 Free PMC article.
Direct Observed Therapy of Chronic Hepatitis C With Interferon-Free All-Oral Regimens at a Low-Threshold Drug Treatment Facility-a New Concept for Treatment of Patients With Borderline Compliance Receiving Opioid Substitution Therapy.
Schìtz A, Moser S, Marchart K, Haltmayer H, Gschwantler M. Schìtz A, et al. Among authors: haltmayer h. Am J Gastroenterol. 2016 Jun;111(6):903-5. doi: 10.1038/ajg.2016.119. Am J Gastroenterol. 2016. PMID: 27249993 No abstract available.
Efficacy of ledipasvir/sofosbuvir plus ribavirin for 12 weeks in patients with chronic hepatitis C genotype 3 and compensated liver disease.
Moser S, Kozbial K, Laferl H, Schütz A, Reiberger T, Schwabl P, Gutic E, Schwanke C, Schubert R, Luhn J, Lang T, Schleicher M, Steindl-Munda P, Haltmayer H, Ferenci P, Gschwantler M. Moser S, et al. Among authors: haltmayer h. Eur J Gastroenterol Hepatol. 2018 Mar;30(3):291-295. doi: 10.1097/MEG.0000000000001027. Eur J Gastroenterol Hepatol. 2018. PMID: 29120906
Directly observed therapy at opioid substitution facilities using sofosbuvir/velpatasvir results in excellent SVR12 rates in PWIDs at high risk for non-adherence to DAA therapy.
Schmidbauer C, Schwarz M, Schütz A, Schubert R, Schwanke C, Gutic E, Pirker R, Lang T, Reiberger T, Haltmayer H, Gschwantler M. Schmidbauer C, et al. Among authors: haltmayer h. PLoS One. 2021 Jun 4;16(6):e0252274. doi: 10.1371/journal.pone.0252274. eCollection 2021. PLoS One. 2021. PMID: 34086708 Free PMC article.